Adenocarcinoma of the Rectum

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-04-04
Clinical Trial Update: Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial of combination chemotherapy and bevacizumab with or without RO4929097 for metastatic colorectal cancer has been withdrawn.